Evidence map›Paper›PMID 19566924›Full record

ArticleBreast cancer research : BCR2009

The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.

Jason G Lieberthal, Marissa Kaminsky, Christopher N Parkhurst, Naoko Tanese

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Liquid-liquid phase separation in tumor biology.Signal transduction and targeted therapy · 2022
    Review
  6. Review
  7. Protein phase separation: A novel therapy for cancer?British journal of pharmacology · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. HybridCancers · 2019
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Heterochromatin protein 1 expression is reduced in human thyroid malignancy.Laboratory investigation; a journal of technical methods and pathology · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jason G LieberthalDepartment of Microbiology and NYU Cancer Institute, New York University School of Medicine, New York, NY 10016, USA. jason.lieberthal@med.nyu.edu
Marissa Kaminsky
Christopher N Parkhurst
Naoko Tanese
New York University · US

Funding

INFECTIOUS DISEASES &BASIC MICROBIOLOGICAL MECHANISMST32AI007180 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 1985 to 2022
$8.9M
NIAID NIH HHS 5T32 AI07180NIAID NIH HHS T32 AI007180
6 · The paper itself

Abstract

introductionHeterochromatin protein 1 (HP1) associates with chromatin by binding to histone H3 and contributes to gene silencing. There are three isoforms of HP1 in mammals: HP1alpha, beta, and gamma. Studies have shown that the level of HP1alpha is reduced in invasive human breast cancer cell lines such as MDA-MB-231 and HS578T compared with non-invasive cell lines such as MCF7 and T47D. It is hypothesized that reduced HP1alpha expression may lead to impaired epigenetic silencing of genes that are important in the acquisition of an invasive phenotype. We set out to determine whether reduced expression of HP1alpha in invasive breast cancer cell lines occurs at the level of transcription.

methodsWe used transient transfection assays to investigate the mechanism of differential transcriptional activity of the human HP1alpha gene promoter in different cell lines. Mutational analysis of putative transcription factor binding sites in an HP1alpha gene reporter construct was performed to identify transcription factors responsible for the differential activity. SiRNA-mediated knockdown and chromatin immunoprecipitation experiments were performed to determine the role of a specific transcription factor in regulating the HP1alpha gene.

resultsThe transcription factor yin yang 1 (YY1) was found to play a role in differential transcriptional activity of the HP1alpha gene. Examination of the YY1 protein and mRNA levels revealed that both were reduced in the invasive cell line HS578T compared with MCF7 cells. YY1 knockdown in MCF7 cells resulted in a decreased level of HP1alpha mRNA, indicating that YY1 positively regulates HP1alpha expression. Chromatin immunoprecipitation experiments verified YY1 occupancy at the HP1alpha gene promoter in MCF7 cells but not HS578T cells. Overexpression of YY1 in HS578T cells decreased cell migration in a manner independent of HP1alpha overexpression.

conclusionsOur data suggests that a reduction of YY1 expression in breast cancer cells could contribute to the acquisition of an invasive phenotype through increased cell migration as well as by reduced expression of HP1alpha.

Indexed as

Gene Expression Regulation, NeoplasticBreast NeoplasmsCell Line, TumorChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneGene Expression ProfilingHistonesHumansMutagenesis, Site-DirectedNeoplasm InvasivenessPhenotypePromoter Regions, GeneticProtein IsoformsRNA, Small InterferingTranscription FactorsYY1 Transcription FactorCBX5 protein, humanChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneHistonesProtein IsoformsRNA, Small InterferingTranscription FactorsYY1 protein, humanYY1 Transcription Factor

Identifiers

PMID19566924
PMCPMC2716511
OpenAlexW2142466020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.